Novo Resources Quote - NVO

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.092

Bid

0.089

Ask

0.097

Volume

34,331

0.092 Day's Range 0.094

0.081 52 Week Range 0.185

Market Cap

32.482M

Previous Close

0.097

Open

0.094

Last Trade

2331

0.092

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

104,811

Shares Outstanding

353,060,847

Dividend Yield

PE Ratio

-48.57

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-1.24M

Sector

Computer Related Svcs, Nec

Industry

Gold Ores

Website

www.nvoi.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

2016

Novo Resources Corp is listed in the Computer Related Svcs sector of the Australian Stock Exchange with ticker NVO. The last closing price for Novo Resources was AUD0.10. Over the last year, Novo Resources shares have traded in a share price range of AUD 0.081 to AUD 0.185.

Novo Resources currently has 353,060,847 shares outstanding. The market capitalization of Novo Resources is AUD34.25 million. Novo Resources has a price to earnings ratio (PE ratio) of -48.57.

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection...

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis...

/K I L L K I L L K I L L - National Changing Diabetes Program/

We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis...

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/...

Novo Nordisk is Changing Possibilities in Hemophilia

Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.007	-7.07070707071	0.099	0.1	0.092	68070	0.09554885	DE
4	0.002	2.22222222222	0.09	0.105	0.089	91390	0.09725307	DE
12	-0.006	-6.12244897959	0.098	0.105	0.086	104811	0.09449082	DE
26	-0.007	-7.07070707071	0.099	0.14	0.081	130339	0.09727655	DE
52	-0.078	-45.8823529412	0.17	0.185	0.081	128139	0.10813845	DE
156	-0.128	-58.1818181818	0.22	0.275	0.081	159312	0.15613953	DE
260	0.084	1050	0.008	0.275	0.005	1045270	0.02494903	DE

NVO - Frequently Asked Questions (FAQ)

What is the current Novo Resources share price?

The current share price of Novo Resources is AUD 0.092

How many Novo Resources shares are in issue?

Novo Resources has 353,060,847 shares in issue

What is the market cap of Novo Resources?

The market capitalisation of Novo Resources is AUD 34.25M

What is the 1 year trading range for Novo Resources share price?

Novo Resources has traded in the range of AUD 0.081 to AUD 0.185 during the past year

What is the PE ratio of Novo Resources?

The price to earnings ratio of Novo Resources is -48.57

What is the reporting currency for Novo Resources?

Novo Resources reports financial results in AUD

What is the latest annual profit for Novo Resources?

The latest annual profit of Novo Resources is AUD -1.24M

What is the registered address of Novo Resources?

The registered address for Novo Resources is LEVEL 5, 126 PHILLIP STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Novo Resources website address?

The website address for Novo Resources is www.nvoi.com.au

Which industry sector does Novo Resources operate in?

Novo Resources operates in the GOLD ORES sector

Symbol	Price	Vol.
MPWMetal Powder Works Ltd	AUD 0.395 (426.67%)	8.63M
TMSOTennant Minerals Ltd	AUD 0.002 (100.00%)	850k
NC6OBNanollose Limited	AUD 0.007 (75.00%)	900k
AAJAruma Resources Ltd	AUD 0.016 (60.00%)	18.96M
AOKAustralian Oil Company Ltd	AUD 0.003 (50.00%)	160.66k
EELENRG Elements Ltd	AUD 0.001 (-50.00%)	382.97k
AVEOAAvecho Biotechnology Limited	AUD 0.001 (-33.33%)	675.22k
LNULinius Technologies Limited	AUD 0.001 (-33.33%)	135k
AGEOCAlligator Energy Limited	AUD 0.002 (-33.33%)	28.78k
ADGOAAdelong Gold Ltd	AUD 0.002 (-33.33%)	8.09M
NICNickel Industries Ltd	AUD 0.6175 (-18.21%)	264.72M
SYASayona Mining Limited	AUD 0.02 (-4.76%)	71.17M
NMGNew Murchison Gold Ltd	AUD 0.013 (4.00%)	64.4M
IMUImugene Limited	AUD 0.033 (-8.33%)	41.33M
VENVintage Energy Ltd	AUD 0.003 (-25.00%)	39.84M

Symbol

Price

Vol.

NICNickel Industries Ltd

AUD 0.6175

(-18.21%)

264.72M

SYASayona Mining Limited

AUD 0.02

(-4.76%)

71.17M

NMGNew Murchison Gold Ltd

AUD 0.013

(4.00%)

64.4M

IMUImugene Limited

AUD 0.033

(-8.33%)

41.33M

VENVintage Energy Ltd

AUD 0.003

(-25.00%)

39.84M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO) Share Price

Novo Resources Corp (NVO)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free